Henry J. Kaminski, MD

Henry J. Kaminski, MD is the Director of the Division and Chairman of the Department of Neurology & Psychiatry. He has a long standing interest in extraocular muscle and their differential involvement by neuromuscular disease, and his research program has received continuous sponsorship by the National Institutes of Health since 1993. He has recently extended his work to development of complement inhibitor-based treatment of myasthenia gravis and muscular dystrophy. He continues to pursue work in understanding the cellular and molecular properties of EOM with the over-arching goal of manipulating EOM function for therapeutic endpoints. He is a member of the Executive Committee of a NIH-sponsored trial to evaluate the role of thymectomy in management of patients with myasthenia gravis and principal investigator of an ancillary study, Biomarkers in Myasthenia Gravis.